Home >> Life Sciences >> Pharmaceuticals

Adult Malignant Glioma Global Clinical Trials Review, H1, 2017

Published: Mar-2017 | Format: PDF | GlobalData | Number of pages: 34 | Code: MRS - 124492

Adult Malignant Glioma Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Adult Malignant Glioma Global Clinical Trials Review, H1, 2017" provides an overview of Adult Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Adult Malignant Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Adult Malignant Glioma to Oncology Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
Clinical Trials by Trial Status 15
Clinical Trials by End Point Status 16
Subjects Recruited Over a Period of Time 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in Adult Malignant Glioma Therapeutics Clinical Trials 20
Clinical Trial Profile Snapshots 21
Appendix 31
Abbreviations 31
Definitions 31
Research Methodology 32
Secondary Research 32
About GlobalData 33
Contact Us 33
Disclaimer 33
Source 34

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

2017-2022 United States Probiotics Market Report (Status and Outlook)

Apr-2017 | LPI (LP Information) | Pages : 115 | Code : MRS-125763 | 3360

The Probiotics market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as DuPont(Danisco) Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Yakult Novozymes Valio G Read more

2017-2022 UK Probiotics Market Report (Status and Outlook)

Apr-2017 | LPI (LP Information) | Pages : 115 | Code : MRS-125762 | 3360

The Probiotics market size will be XX million (USD) in 2022 in UK, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In UK market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as DuPont(Danisco) Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Yakult Novozymes Valio Glory Biotech Gane Read more

2017-2022 Japan Probiotics Market Report (Status and Outlook)

Apr-2017 | LPI (LP Information) | Pages : 115 | Code : MRS-125761 | 3360

The Probiotics market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as DuPont(Danisco) Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Yakult Novozymes Valio Glory Biotech Read more

2017-2022 India Probiotics Market Report (Status and Outlook)

Apr-2017 | LPI (LP Information) | Pages : 115 | Code : MRS-125760 | 3360

The Probiotics market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as DuPont(Danisco) Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Yakult Novozymes Valio Glory Biotech Read more

2017-2022 Germany Probiotics Market Report (Status and Outlook)

Apr-2017 | LPI (LP Information) | Pages : 115 | Code : MRS-125759 | 3360

The Probiotics market size will be XX million (USD) in 2022 in Germany, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Germany market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as DuPont(Danisco) Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Yakult Novozymes Valio Glory Biotech Read more

2017-2022 China Probiotics Market Report (Status and Outlook)

Apr-2017 | LPI (LP Information) | Pages : 115 | Code : MRS-125758 | 3360

The Probiotics market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as DuPont(Danisco) Chr. Hansen Lallemand China-Biotics Nestle Danone Probi BioGaia Yakult Novozymes Valio Glory Biotech Read more

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016

Apr-2017 | GlobalData | Pages : 111 | Code : MRS-125649 | 1500

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016”, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private e Read more

Global Ginkgo Biloba Extract Industry Market Research 2017

Apr-2017 | HJResearch | Pages : 154 | Code : MRS-125560 | 2600

In this report, we analyze the Ginkgo Biloba Extract industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We als Read more

Global Drug Coated Stent Industry Market Research 2017

Apr-2017 | HJResearch | Pages : 157 | Code : MRS-125558 | 2600

In this report, we analyze the Drug Coated Stent industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also ma Read more

Global Silica Gel Wound Dressing Industry Market Research 2017

Apr-2017 | HJResearch | Pages : 154 | Code : MRS-125557 | 2600

In this report, we analyze the Silica Gel Wound Dressing industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We Read more

Single User | $(USD)2500 View Pricing